Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial
dc.contributor.author | Siddharthan, Trishul | |
dc.contributor.author | Pollard, Suzanne L. | |
dc.contributor.author | Sekitoleko, Isaac | |
dc.contributor.author | Namazzi, Esther | |
dc.contributor.author | Alupo, Patricia | |
dc.contributor.author | Kalyesubula, Robert | |
dc.contributor.author | Kirenga, Bruce | |
dc.date.accessioned | 2022-05-19T05:46:56Z | |
dc.date.available | 2022-05-19T05:46:56Z | |
dc.date.issued | 2021 | |
dc.description.abstract | COPD is a leading cause of death globally, with the majority of morbidity and mortality occurring in low- and middle-income country (LMIC) settings. While tobacco-smoke exposure is the most important risk factor for COPD in high-income settings, household air pollution from biomass smoke combustion is a leading risk factor for COPD in LMICs. Despite the high burden of biomass smoke-related COPD, few studies have evaluated the efficacy of pharmacotherapy in this context. Currently recommended inhaler-based therapy for COPD is neither available nor affordable in most resource-limited settings. Low-dose theophylline is an oral, once-a-day therapy, long used in high-income countries (HICs), which has been proposed for the management of COPD in LMICs in the absence of inhaled steroids and/or bronchodilators. The Low-dose Theophylline for the Management of Biomass-Associated COPD (LODOT-BCOPD) trial investigates the clinical efficacy and cost-effectiveness of low-dose theophylline for the management of biomass-related COPD in a low-income setting. | en_US |
dc.identifier.citation | Siddharthan, T., Pollard, S. L., Jackson, P., Robertson, N. M., Wosu, A. C., Rahman, N., ... & Kirenga, B. (2021). Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial. Trials, 22(1), 1-9.https://doi.org/10.1186/s13063-021-05163-2 | en_US |
dc.identifier.uri | https://nru.uncst.go.ug/handle/123456789/3260 | |
dc.language.iso | en | en_US |
dc.publisher | Trials | en_US |
dc.subject | Biomass, COPD, Theophylline | en_US |
dc.title | Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial | en_US |
dc.type | Article | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Effectiveness of low-dose theophylline for.pdf
- Size:
- 817.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Effectiveness of low-dose theophylline for the management of biomass-associated COPD (LODOT-BCOPD): study protocol for a randomized controlled trial
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: